Join Now

Category Archives: BioUtah News

Sethera Therapeutics Completes First Funding Round

By Natalie Themm | Published January 2, 2025

Sethera Therapeutics Completes First Funding Round

| Tagged | Comments Off on Sethera Therapeutics Completes First Funding Round

Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis

By Natalie Themm | Published January 2, 2025

Data from Dual-Acting Oral Biologic Show Promising Safety and Efficacy Profile

| Tagged | Comments Off on Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis

CancerVax Passes First Test with Flying Colors

By Natalie Themm | Published January 2, 2025

Recent in-vitro lab results confirm that the Company’s Smart mRNA can be used as a potential on/off switch for selectively detecting cancer cells

| Tagged | Comments Off on CancerVax Passes First Test with Flying Colors

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis

By Natalie Themm | Published January 2, 2025

Unique cell-impermeable1 design extends life-saving treatment for dialysis patients.

| Tagged | Comments Off on Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis

Here’s how Utah earned its No. 1 ranking for innovation

By Natalie Themm | Published December 19, 2024

A new report from the U.’s Kem C. Gardner Policy Institute uncovers the wide-ranging mechanisms driving Utah’s high performance when it comes to innovation output

| Comments Off on Here’s how Utah earned its No. 1 ranking for innovation

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

By Natalie Themm | Published December 19, 2024

Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinics. The program, launching this month, will run for a minimum of three years.

| Tagged | Comments Off on Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

By Natalie Themm | Published December 19, 2024

Study Demonstrates RiskScore as a More Accurate Predictor of Breast Cancer Risk, Doubling Accuracy Compared to the Tyrer-Cuzick Model

| Tagged | Comments Off on Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

Human Forms and Body Parts Trigger Strong Reactions in the Brain

By Natalie Themm | Published December 19, 2024

Human Forms and Body Parts Trigger Strong Reactions in the Brain

| Tagged | Comments Off on Human Forms and Body Parts Trigger Strong Reactions in the Brain

Canary Speech and Prism Care Announce Partnership to Enhance Extended Care Through Vocal Biomarker Technology

By Natalie Themm | Published December 19, 2024

Partnership aims to set new industry standards for managing mental health and cognitive conditions

| Tagged | Comments Off on Canary Speech and Prism Care Announce Partnership to Enhance Extended Care Through Vocal Biomarker Technology

SINTX TECHNOLOGIES SECURES PATENT ALLOWANCE FOR WIDE-RANGING SILICON NITRIDE BIOMATERIAL APPLICATIONS

By Natalie Themm | Published December 19, 2024

SINTX TECHNOLOGIES SECURES PATENT ALLOWANCE FOR WIDE-RANGING SILICON NITRIDE BIOMATERIAL APPLICATIONS

| Tagged | Comments Off on SINTX TECHNOLOGIES SECURES PATENT ALLOWANCE FOR WIDE-RANGING SILICON NITRIDE BIOMATERIAL APPLICATIONS

BD Resolves Previously Disclosed SEC Investigation

By Natalie Themm | Published December 19, 2024

BD has reached an agreement with the U.S. SEC to resolve the previously disclosed investigation related to prior public disclosures.

| Tagged | Comments Off on BD Resolves Previously Disclosed SEC Investigation

NUSANO NAMES MEDICAL RADIOISOTOPES ADVISORY BOARD

By admin | Published December 12, 2024

VALENCIA, Calif. – Dec. 3, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the creation of a Medical Radioisotopes Advisory Board. This panel of internationally recognized leaders in nuclear medicine will provide strategic guidance to Nusano, ensuring its product development aligns with emerging trends and with the needs of cancer […]

| Comments Off on NUSANO NAMES MEDICAL RADIOISOTOPES ADVISORY BOARD

A Special Thanks To Our Legacy and Platinum Elite Members